Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 133.00M | £ 228.00M | £ 113.20M | £ 113.60M | £ 146.80M |
Total Assets | £ 981.30M | £ 859.10M | £ 709.60M | £ 652.80M | £ 750.80M |
Total Debt | £ 435.70M | £ 393.80M | £ 384.10M | £ 366.40M | £ 174.70M |
Net Debt | £ 302.70M | £ 165.80M | £ 270.90M | £ 252.80M | £ 27.90M |
Total Liabilities | £ 634.80M | £ 530.90M | £ 506.00M | £ 502.10M | £ 650.40M |
Stockholders Equity | £ 346.50M | £ 328.20M | £ 203.60M | £ 150.70M | £ 100.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |